164 related articles for article (PubMed ID: 33761701)
1. Preoperative neoadjuvant targeted therapy with apatinib for inoperable differentiated thyroid cancer: A case report.
Zhang Y; Deng X; Ding Z; Kang J; Wu B; Guo B; Fan Y
Medicine (Baltimore); 2021 Mar; 100(12):e25191. PubMed ID: 33761701
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Results of a Phase II Trial of Apatinib for Progressive Radioiodine Refractory Differentiated Thyroid Cancer.
Lin YS; Zhang X; Wang C; Liu YQ; Guan WM; Liang J
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3027-e3036. PubMed ID: 33769497
[TBL] [Abstract][Full Text] [Related]
3. Overwhelming rapid metabolic and structural response to apatinib in radioiodine refractory differentiated thyroid cancer.
Lin Y; Wang C; Gao W; Cui R; Liang J
Oncotarget; 2017 Jun; 8(26):42252-42261. PubMed ID: 28178685
[TBL] [Abstract][Full Text] [Related]
4. De-differentiation of papillary thyroid carcinoma into squamous cell carcinoma in an elderly patient: A case report.
Thewjitcharoen Y; Krittiyawong S; Butadej S; Nakasatien S; Polchart S; Junyangdikul P; Kanchanapituk A; Himathongkam T
Medicine (Baltimore); 2020 Apr; 99(16):e19892. PubMed ID: 32312017
[TBL] [Abstract][Full Text] [Related]
5. Case Report: A New Entity: Multiple Differentiated Variant of Papillary Thyroid Carcinoma With Advanced Clinical Behavior.
Yang J; Gong R; Ma Y; Gao J; Li Z; Zhu J; Gong Y
Front Endocrinol (Lausanne); 2021; 12():654638. PubMed ID: 33897621
[TBL] [Abstract][Full Text] [Related]
6. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
[TBL] [Abstract][Full Text] [Related]
7. Treatment with sorafenib in advanced thyroid cancer - a case report.
Krajewska J; Olczyk T; Roskosz J; Paliczk-Cieślik E; Smietana AK; Kaczmarek-Borowska B; Jarząb B
Endokrynol Pol; 2010; 61(5):492-6. PubMed ID: 21049464
[TBL] [Abstract][Full Text] [Related]
8. Response to Lenvatinib in Children with Papillary Thyroid Carcinoma.
Mahajan P; Dawrant J; Kheradpour A; Quintanilla NM; Lopez ME; Orth RC; Athanassaki I; Venkatramani R
Thyroid; 2018 Nov; 28(11):1450-1454. PubMed ID: 30226445
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of preoperative radioactive iodine (131I) therapy for locally advanced papillary thyroid cancer: a case report.
Shingu K; Kobayashi S; Yokoyama S; Shimizu T; Kasuga Y; Fujimori M; Ito K; Hama Y; Amano J
Thyroid; 1998 Dec; 8(12):1113-6. PubMed ID: 9920366
[TBL] [Abstract][Full Text] [Related]
10. Papillary thyroid carcinoma with tracheal invasion: A case report.
Zhang J; Fu C; Cui K; Ma X
Medicine (Baltimore); 2019 Sep; 98(38):e17033. PubMed ID: 31567939
[TBL] [Abstract][Full Text] [Related]
11. Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC).
Shi L; You Q; Wang J; Wang H; Li S; Tian R; Yao X; Wu W; Zhang L; Wang F; Lin Y; Li S
Endocrine; 2022 Oct; 78(1):68-76. PubMed ID: 35767182
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of papillary thyroid carcinoma from the residual pyramidal lobe: a case report and literature review.
Wang M; Zou X; Li Z; Zhu J
Medicine (Baltimore); 2019 Apr; 98(15):e15210. PubMed ID: 30985719
[TBL] [Abstract][Full Text] [Related]
13. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
14. Clinical responses to vemurafenib in postoperative recurrence of papillary thyroid carcinoma with esophageal fistula: A case report.
He S; Lu W; Ding X; Zhou J; Liu D; Zhu Y; Yang F; Fu Z
Medicine (Baltimore); 2024 Mar; 103(11):e37513. PubMed ID: 38489728
[TBL] [Abstract][Full Text] [Related]
15. Response to apatinib and camrelizumab combined treatment in a radioiodine refractory differentiated thyroid cancer patient resistant to prior anti-angiogenic therapy: A case report and literature review.
Li J; Zhang X; Mu Z; Sun D; Sun Y; Lin Y
Front Immunol; 2022; 13():943916. PubMed ID: 36003403
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of locally advanced papillary thyroid carcinoma after response to lenvatinib: A case report.
Tsuboi M; Takizawa H; Aoyama M; Tangoku A
Int J Surg Case Rep; 2017; 41():89-92. PubMed ID: 29055877
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous radioiodine and recombinant human TSH in a patient with extensive thyroid cáncer. Report of one case].
Spuler J; Paillahueque G; González P; Campos D
Rev Med Chil; 2018 Dec; 146(10):1220-1223. PubMed ID: 30724989
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Apatinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma.
Du W; Shi X; Fang Q; Zhang X; Liu S
Front Endocrinol (Lausanne); 2022; 13():768028. PubMed ID: 35282451
[TBL] [Abstract][Full Text] [Related]
19. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713
[TBL] [Abstract][Full Text] [Related]
20. Occult papillary thyroid cancer presenting as cystic metastasis of the lateral neck: A case report.
Schwaiger K; Koeninger F; Wimbauer J; Heinrich K; Gala-Kokalj A; Wechselberger G
Medicine (Baltimore); 2019 Jul; 98(30):e16659. PubMed ID: 31348321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
